Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for RGEDF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 2006. Start Trial.
Date Value
May 31, 2026 56.37%
April 30, 2026 56.37%
March 31, 2026 56.37%
February 28, 2026 56.37%
January 31, 2026 56.37%
December 31, 2025 56.37%
November 30, 2025 56.37%
October 31, 2025 56.37%
September 30, 2025 56.37%
August 31, 2025 56.37%
July 31, 2025 56.37%
June 30, 2025 56.37%
May 31, 2025 56.37%
April 30, 2025 56.37%
March 31, 2025 56.37%
February 28, 2025 56.37%
January 31, 2025 56.37%
December 31, 2024 56.37%
November 30, 2024 56.37%
October 31, 2024 56.37%
September 30, 2024 56.37%
August 31, 2024 56.37%
July 31, 2024 56.37%
June 30, 2024 56.37%
May 31, 2024 56.37%
Date Value
April 30, 2024 56.37%
March 31, 2024 56.37%
February 29, 2024 56.37%
January 31, 2024 56.37%
December 31, 2023 56.37%
November 30, 2023 56.37%
October 31, 2023 56.37%
September 30, 2023 56.37%
August 31, 2023 56.37%
July 31, 2023 89.20%
June 30, 2023 90.43%
May 31, 2023 90.43%
April 30, 2023 90.43%
March 31, 2023 90.43%
February 28, 2023 90.43%
January 31, 2023 90.43%
December 31, 2022 90.43%
November 30, 2022 90.43%
October 31, 2022 90.43%
September 30, 2022 90.43%
August 31, 2022 90.43%
July 31, 2022 90.43%
June 30, 2022 90.43%
May 31, 2022 90.43%
April 30, 2022 90.43%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
AstraZeneca PLC 27.87%
ANI Pharmaceuticals, Inc. 72.96%
Corcept Therapeutics, Inc. 71.85%
Assertio Holdings, Inc. 99.16%
Veru, Inc. 99.12%